Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of “Hold” from Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have been given a consensus recommendation of “Hold” by the thirteen brokerages that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $2.9318.

Several brokerages have recently issued reports on HCAT. Stephens reduced their price objective on Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Cantor Fitzgerald restated a “neutral” rating on shares of Health Catalyst in a research report on Monday, May 11th. Citigroup cut their target price on Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Canaccord Genuity Group boosted their price target on Health Catalyst from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Tuesday, July 21st. Finally, Weiss Ratings raised Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 28th.

Health Catalyst Stock Up 0.6%

HCAT stock opened at $1.71 on Wednesday. The company has a quick ratio of 2.70, a current ratio of 2.70 and a debt-to-equity ratio of 1.51. Health Catalyst has a fifty-two week low of $0.96 and a fifty-two week high of $3.80. The firm’s 50-day simple moving average is $2.00 and its 200 day simple moving average is $1.68. The stock has a market cap of $128.69 million, a PE ratio of -0.46 and a beta of 1.55.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. The firm had revenue of $70.49 million for the quarter, compared to the consensus estimate of $69.09 million. As a group, sell-side analysts predict that Health Catalyst will post -0.25 EPS for the current year.

Hedge Funds Weigh In On Health Catalyst

Several large investors have recently bought and sold shares of HCAT. AQR Capital Management LLC lifted its stake in shares of Health Catalyst by 816.8% in the 1st quarter. AQR Capital Management LLC now owns 168,344 shares of the company’s stock worth $763,000 after acquiring an additional 149,981 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Health Catalyst by 7.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company’s stock valued at $163,000 after acquiring an additional 2,624 shares in the last quarter. Focus Partners Wealth acquired a new position in shares of Health Catalyst during the first quarter valued at approximately $46,000. Geode Capital Management LLC increased its stake in shares of Health Catalyst by 11.4% during the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after acquiring an additional 169,580 shares during the period. Finally, Rhumbline Advisers raised its holdings in Health Catalyst by 13.5% during the second quarter. Rhumbline Advisers now owns 101,986 shares of the company’s stock worth $384,000 after purchasing an additional 12,127 shares in the last quarter. Institutional investors and hedge funds own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.